title: Humoral changes during a long-term antihypertensive treatment.
authors.affiliation: 2nd Medical Department, Charles University, Prague, Czechoslovakia.
authors.forename: J
authors.initials: J
authors.lastname: Peleska
authors.forename: A
authors.initials: A
authors.lastname: Jindra
authors.forename: M
authors.initials: M
authors.lastname: Jáchymová
authors.forename: J
authors.initials: J
authors.lastname: Zvárová
authors.forename: J
authors.initials: J
authors.lastname: Savliková
authors.forename: M
authors.initials: M
authors.lastname: Jarolim
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines / Q000627:therapeutic use; D002046:Bupranolol / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007610:Kallikreins / Q000652:urine; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine; D013997:Time Factors; D014223:Triamterene / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004338:Drug Combinations; D005231:Fatty Acids, Unsaturated; C025276:bemetizide, bupranolol, triamterene drug combination; D002046:Bupranolol; D012964:Sodium; D007610:Kallikreins; D012083:Renin; D011188:Potassium; D014223:Triamterene